[
  {"doc_id":"F2020-AR-C020","type":"Annual Report","date":"2021-03-01","title":"2020 Annual Report","body":"BioHarvest reported $16.8M revenue from early produce sales. Demonstrated PhytoCell lettuce, attracting media and investor interest. ESG initiative: water recycling program piloted. Risks: scalability and energy costs."},
  {"doc_id":"F2021-AR-C020","type":"Annual Report","date":"2022-02-28","title":"2021 Annual Report","body":"Revenue $34.1M, Nestlé licensing signed. Business model expanded toward IP licensing. ESG: rural farming empowerment programs."},
  {"doc_id":"F2022-AR-C020","type":"Annual Report","date":"2023-02-27","title":"2022 Annual Report","body":"Revenue $62.4M, FDA GRAS granted for Nutrivine additive allowing commercial US sales. Risks: adoption rate of novel foods. ESG: solar expansion in vertical farming."},
  {"doc_id":"F2023-AR-C020","type":"Annual Report","date":"2024-02-29","title":"2023 Annual Report","body":"Revenue $94.8M, Coca‑Cola partnership signed. Strong growth in IP licensing. Margins pressured by energy prices. ESG: zero‑deforestation pledge."},
  {"doc_id":"F2024-AR-C020","type":"Annual Report","date":"2025-02-28","title":"2024 Annual Report","body":"Revenue $119.2M despite high energy risks, PPAs signed stabilized future exposures. Scaling biotech farms. ESG: equal gender hiring reached 50%. Risks: volatility in energy and food regulation."},
  {"doc_id":"DEMO-2020-05-C020","type":"Demo Report","date":"2020-05-22","title":"PhytoCell Lettuce Demo","body":"BioHarvest showcased first edible leafy crop produced via PhytoCell tech inside vertical farm. Coverage gained from media worldwide."},
  {"doc_id":"CONTRACT-2021-11-C020","type":"Contract Document","date":"2021-11-04","title":"Nestlé Licensing Deal","body":"Signed agreement with Nestlé licensing PhytoCell actives for nutraceutical markets. Provided annual royalty streams and milestone payments."},
  {"doc_id":"GRAS-2022-08-C020","type":"Regulatory Filing","date":"2022-08-13","title":"FDA GRAS Approval","body":"Food additive Nutrivine cell-grown wine enhancer approved as GRAS by FDA, unlocking US commercialization."},
  {"doc_id":"PART-2023-09-C020","type":"Partnership","date":"2023-09-19","title":"Coca‑Cola Ingredient Supply","body":"Multi‑year agreement to supply cell‑derived phytonutrients into Coca‑Cola wellness beverages. Initial $20M deal value."},
  {"doc_id":"ISSUE-2024-03-C020","type":"Operations Alert","date":"2024-03-06","title":"Energy Cost Spike","body":"High electricity prices hit vertical farms. Q1 margins lowered by 200bps. Management accelerated renewable PPAs."},
  {"doc_id":"RESOLVE-2024-10-C020","type":"Resolution Note","date":"2024-10-11","title":"Solar PPAs Signed","body":"Company contracted multiple solar suppliers in Israel, Spain, and US to stabilize farm energy costs long‑term."},
  {"doc_id":"JV-2025-02-C020","type":"Joint Venture","date":"2025-02-10","title":"Bayer Global JV","body":"JV with Bayer CropScience to advance precision traits and cell‑agriculture platform. Future licensing and product collaborations expected."},
  {"doc_id":"ER-2025-08-C020","type":"Earnings Release","date":"2025-08-19","title":"Q2 2025 Earnings","body":"Reported record revenues of $21.8M Q2 from Nestlé, Coca‑Cola, and farm produce. EPS 0.49. Guidance raised for FY."}
]
